Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use

Objective  To evaluate whether continuation rates with the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) up to 5 years after placement differed between women using the method exclusively for contraception and those using the device for medical reasons alone. Methods  A retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Laura, Sousa, Maria Helena de, Faundes, Anibal, Juliato, Cássia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183879/
https://www.ncbi.nlm.nih.gov/pubmed/33979890
http://dx.doi.org/10.1055/s-0041-1726056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183879/
https://www.ncbi.nlm.nih.gov/pubmed/33979890
http://dx.doi.org/10.1055/s-0041-1726056

Ejemplares similares